中华放射肿瘤学杂志
Wednesday, Apr. 2, 2025   Home | Journal | Editorial | Instruction | Subscription | Advertisement | Academic | Index-in | Contact Us | Chinese
Chinese Journal of Radiation Oncology  2020, Vol. 29 Issue (8): 644-648    DOI: 10.3760/cma.j.cn113030-20200301-00082
Thoracic Tumors Current Issue| Next Issue| Archive| Adv Search [an error occurred while processing this directive] | [an error occurred while processing this directive]
Relationship between adjuvant radiotherapy dose and pathologic complete response in patients with locally advanced esophageal squamous cell cancer
Zeng Xiaoxiao1,4, Sun Hongna1, Wei Hao1, Xu Yong1, Zhou Xiaojuan1, Ding Zhenyu2, Gong Youling1, Wang Jin1, Zhou Lin1, Lu You1, Yuan Yong3, Hu Yang3, Liu Yongmei1
1 Department of Thoracic Cancer, WestChina Hospital, Sichuan University, Chengdu 610041, China;
2 Department of Biotherapy, WestChina Hospital, Sichuan University, Chengdu 610041, China;
3 Department of Thoracic Surgery, WestChina Hospital, Sichuan University, Chengdu 610041, China;
4 Department of Oncology Ⅱ, Jianyang People's Hospital, Jianyan 641400, China
Download: PDF (0 KB)   HTML (1 KB) 
Export: BibTeX | EndNote (RIS)      Supporting Info
Abstract  Objective To investigate the relationship between the dose of preoperative neoadjuvant radiotherapy and the pathologic complete response (pCR) rate in patients with locally advanced squamous cell esophageal cancer (ESCC). Methods Clinical data of 116 patients with ESCC who received neoadjuvant chemoradiotherapy followed by esophagectomy in our cancer center from July 2017 to December 2019 were retrospectively analyzed. The radiation doses were divided into 2 ranges based on Grays (Gy) received:40-45 Gy and 45 Gy or more. Results The overall pCR rate was 38. 8%(45/116). pCR was observed in 35 out of 80(44%) patients treated with 40-45 Gy and 10 of 36(28%) patients treated with 45 Gy or more. The pCR rate did not significantly differ between two groups [(40-45 Gy) vs.( ≥ 45 Gy), P=0.105)]. Conclusions Preoperative neoadjuvant radiotherapy with a higher dose (≥ 45 Gy) fails to increase the pCR rate in patients with locally advanced ESCC. Prospective randomized trials are required to determine the optimal dose of preoperative adjuvant radiotherapy.
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
Zeng Xiaoxiao
Sun Hongna
Wei Hao
Xu Yong
Zhou Xiaojuan
Ding Zhenyu
Gong Youling
Wang Jin
Zhou Lin
Lu You
Yuan Yong
Hu Yang
Liu Yongmei
Key wordsEsophageal neoplasm/neoadjuvant radiochemotherapy      Dose of preoperative radiotherapy      Pathologic complete response     
Received: 01 March 2020     
Fund:Health Commission of Sichuan Province(16ZD005)
Corresponding Authors: Liu Yongmei, Email:lymi75@163.com   
Cite this article:   
Zeng Xiaoxiao,Sun Hongna,Wei Hao et al. Relationship between adjuvant radiotherapy dose and pathologic complete response in patients with locally advanced esophageal squamous cell cancer[J]. Chinese Journal of Radiation Oncology, 2020, 29(8): 644-648.
Zeng Xiaoxiao,Sun Hongna,Wei Hao et al. Relationship between adjuvant radiotherapy dose and pathologic complete response in patients with locally advanced esophageal squamous cell cancer[J]. Chinese Journal of Radiation Oncology, 2020, 29(8): 644-648.
URL:  
http://journal12.magtechjournal.com/Jweb_fszlx/EN/10.3760/cma.j.cn113030-20200301-00082     OR     http://journal12.magtechjournal.com/Jweb_fszlx/EN/Y2020/V29/I8/644
  Copyright © 2010 Editorial By Chinese Journal of Radiation Oncology
Support by Beijing Magtech Co.ltd  support@magtech.com.cn